144 related articles for article (PubMed ID: 28841682)
21. Functional and clinicopathological analysis of loss of MKK4 expression in endometrial cancer.
Ishikawa M; Nakayama K; Rahman MT; Rahman M; Katagiri A; Iida K; Miyazaki K
Oncology; 2010; 79(3-4):238-46. PubMed ID: 21372598
[TBL] [Abstract][Full Text] [Related]
22. Downregulation of Melanoma Cell Adhesion Molecule (MCAM/CD146) Accelerates Cellular Senescence in Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells.
Jin HJ; Kwon JH; Kim M; Bae YK; Choi SJ; Oh W; Yang YS; Jeon HB
Stem Cells Transl Med; 2016 Apr; 5(4):427-39. PubMed ID: 26941359
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer.
Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y
Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583
[TBL] [Abstract][Full Text] [Related]
24. Macrophage migration inhibitory factor up-regulates alpha(v)beta(3) integrin and vascular endothelial growth factor expression in endometrial adenocarcinoma cell line Ishikawa.
Bondza PK; Metz CN; Akoum A
J Reprod Immunol; 2008 Apr; 77(2):142-51. PubMed ID: 17854909
[TBL] [Abstract][Full Text] [Related]
25. The adult stem cell marker Musashi-1 modulates endometrial carcinoma cell cycle progression and apoptosis via Notch-1 and p21WAF1/CIP1.
Götte M; Greve B; Kelsch R; Müller-Uthoff H; Weiss K; Kharabi Masouleh B; Sibrowski W; Kiesel L; Buchweitz O
Int J Cancer; 2011 Oct; 129(8):2042-9. PubMed ID: 21165952
[TBL] [Abstract][Full Text] [Related]
26. Reduced expression of sushi domain containing 2 is associated with progression of non-small cell lung cancer.
Cai C; Shi R; Gao Y; Zeng J; Wei M; Wang H; Zheng W; Ma W
Oncol Lett; 2015 Dec; 10(6):3619-3624. PubMed ID: 26788179
[TBL] [Abstract][Full Text] [Related]
27. Biologically inhibitory effects of VEGF siRNA on endometrial carcinoma cells.
Zhao S; Ma D; Dai H; Yuan F; Wang Z
Arch Gynecol Obstet; 2011 Dec; 284(6):1533-41. PubMed ID: 22057922
[TBL] [Abstract][Full Text] [Related]
28. Effects of 1alpha, 25-dihydroxyvitamin D
Kim TH; Park J; Lee JS; Lee HH
J Obstet Gynaecol; 2017 May; 37(4):503-509. PubMed ID: 28421904
[TBL] [Abstract][Full Text] [Related]
29.
Rahimipour M; Jafarabadi M; Salehnia M
Cell J; 2021 Jul; 23(2):154-163. PubMed ID: 34096216
[TBL] [Abstract][Full Text] [Related]
30. The influence of the WWOX gene on the regulation of biological processes during endometrial carcinogenesis.
Płuciennik E; Nowakowska M; Gałdyszyńska M; Popęda M; Bednarek AK
Int J Mol Med; 2016 Mar; 37(3):807-15. PubMed ID: 26820701
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of estrogen receptor-alpha in the endometrial carcinoma cell line Ishikawa: inhibition of growth and angiogenic factors.
Ali SH; O'Donnell AL; Mohamed S; Mousa S; Dandona P
Gynecol Oncol; 2004 Dec; 95(3):637-45. PubMed ID: 15581976
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition.
So KA; Min KJ; Hong JH; Lee JK
Int J Oncol; 2015 Oct; 47(4):1451-9. PubMed ID: 26316317
[TBL] [Abstract][Full Text] [Related]
33. [Regulation of claudin-4 gene expression in endometrial adenocarcinoma Ishikawa cell line by progesterone].
Jin Y; Feng CP; Wang YN; Lin H; Li HJ; Pan XY
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):368-72. PubMed ID: 22883527
[TBL] [Abstract][Full Text] [Related]
34. Akt regulates COX-2 mRNA and protein expression in mutated-PTEN human endometrial cancer cells.
St-Germain ME; Gagnon V; Mathieu I; Parent S; Asselin E
Int J Oncol; 2004 May; 24(5):1311-24. PubMed ID: 15067356
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of Transforming Growth Factor-β Receptor signaling promotes culture expansion of undifferentiated human Endometrial Mesenchymal Stem/stromal Cells.
Gurung S; Werkmeister JA; Gargett CE
Sci Rep; 2015 Oct; 5():15042. PubMed ID: 26461813
[TBL] [Abstract][Full Text] [Related]
36. [Preliminary investigation of the expression and functions of insulin receptor isoforms in endometrial carcinoma].
Zhang G; Li XP; Wang JL; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Nov; 47(11):839-45. PubMed ID: 23302125
[TBL] [Abstract][Full Text] [Related]
37. Regulation of the vascular endothelial growth factor and growth by estrogen and antiestrogens through Efp in Ishikawa endometrial carcinoma cells.
Dai H; Zhang P; Zhao S; Zhang J; Wang B
Oncol Rep; 2009 Feb; 21(2):395-401. PubMed ID: 19148513
[TBL] [Abstract][Full Text] [Related]
38. Mechanism and functional consequences of loss of FOXO1 expression in endometrioid endometrial cancer cells.
Goto T; Takano M; Albergaria A; Briese J; Pomeranz KM; Cloke B; Fusi L; Feroze-Zaidi F; Maywald N; Sajin M; Dina RE; Ishihara O; Takeda S; Lam EW; Bamberger AM; Ghaem-Maghami S; Brosens JJ
Oncogene; 2008 Jan; 27(1):9-19. PubMed ID: 17599040
[TBL] [Abstract][Full Text] [Related]
39. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
[TBL] [Abstract][Full Text] [Related]
40. Autocrine motility factor promotes epithelial-mesenchymal transition in endometrial cancer via MAPK signaling pathway.
Li Y; Che Q; Bian Y; Zhou Q; Jiang F; Tong H; Ke J; Wang K; Wan XP
Int J Oncol; 2015 Sep; 47(3):1017-24. PubMed ID: 26201353
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
